Stay updated with breaking news from Valve Replacement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TRILUMINATE, the first pivotal trial of a device for repair of severe tricuspid regurgitation, showed a large reduction in valve dysfunction associated with substantial improvement in quality of life.
Newark, New Castle, USA, March 01, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Cardiovascular Medical Tourism Market by...
Letters sent by the FDA and Abbott warn about a potential risk of early structural valve deterioration with the Abbott Trifecta valve and Trifecta valve with glide technology.
A new meta-analysis of trials comparing TAVI to surgery for aortic valve stenosis highlights a high rate of potential bias in the trials, researchers conclude.
>> you just dropped the academy award. >> yeah. we're doing two other big specials, one on open heart surgery and one with somebody else i can't announce yet. >> we're going to do four specials. >> you always did -- whatever i did -- i just want to say when you say it's the last time i'm going to be on with you, oh, gee, we've had so many good times together. but you've been on, what, 25 years? why did i miss those five years? what's wrong? five years -- >> we were nothing then. you came on when we were a hit. by the way, the open -- did you have open heart surgery? that's a misnomer in a sens...